Accelerating Time-to-Insight

Pietro Forgione
Vice President, Strategy, Marketing and Product, IDBS

See all i3 2022 Sessions

About the Session:

In this session, we will frame up the importance of time-to-market for new drugs, and explore the impact insight and understanding have in helping to reduce timelines across the BioPharmaceutical lifecycle. There are different approaches to delivering insight, and we will explore the challenges and opportunities as well as the importance of contextualization.

Watch the Session

You may also like these sessions:

Accelerating Time-to-Insight

22nd June 2022 | 30 minutes

In this session we will frame up the importance of time-to-market for new drugs, and explore the impact insight and understanding have in helping to reduce timelines across the BioPharma lifecycle.

Watch session

Closing Note

23rd June 2022 | 30 minutes

Christian Marcazzo, General Manager of IDBS, closes i3 2022 and is joined by Brian Hobbs, Engineering Director.

Watch session
See all i3 2022 Sessions
Pietro Forgione

Pietro joined IDBS in 2006 and has more than 18 years of experience in the BioPharmaceutical industry. As Vice President of Strategy, Product and Marketing, Pietro is leading innovation with a focus on accelerating the discovery of breakthrough products and the development of life changing vaccines and therapies.
Pietro has a deep understanding of the way in which digital transformation and data helps drive innovation and time to market across new product discovery, development and manufacturing. Pietro has held several roles at IDBS including Head of Global Strategic Sales and Vice President of Sales, EMEA. Pietro has a first-class honors degree in Biotechnology from the University of Nottingham.